Radamés Bezerra Melo, Gabriella Alves Julião Costa, Paulo Goberlânio de Barros Silva, Reinaldo Barreto Oriá, Cristhyane Costa de Aquino, Paulo Roberto Leitão Vasconcelos
{"title":"Effects of low omega-6/omega-3 ratio and high omega-9/omega-6 ratio oil blend on inflammation and oxidative stress after tooth extraction in rats.","authors":"Radamés Bezerra Melo, Gabriella Alves Julião Costa, Paulo Goberlânio de Barros Silva, Reinaldo Barreto Oriá, Cristhyane Costa de Aquino, Paulo Roberto Leitão Vasconcelos","doi":"10.1007/s10787-025-01892-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated the effects and mechanisms of antioxidant and anti-inflammatory oils with a high omega-9:omega-6 ratio and a low omega-6:omega-3 ratio on post-extraction healing in rats.</p><p><strong>Materials and methods: </strong>A total of 128 Wistar rats were divided into four groups: Sham, Saline, Isolipidic, and Anti-inflammatory/Antioxidant. The animals received one of the following treatments: (1) 0.9% NaCl solution (Sham Group or Saline Group); (2) an isolipidic mixture containing alpha-linolenic acid (ALA) and a combination of ω-9, ω-6, and ω-3 fatty acids derived from corn oil and soybean oil-rich in omega-6:omega-3 and omega-9:omega-6 ratios (Isolipidic Group); or (3) an anti-inflammatory and antioxidant mixture containing ALA, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA), composed of olive oil (61%), canola oil (24%), and fish oil (15%) (Test Group). Treatments were administered by gavage for four days pre-extraction and three days post-surgery. Animals were euthanized at 3, 7, 14, and 21 days post-extraction. Blood and tissue samples were analyzed for myeloperoxidase, osteoclast count, IL-1β, NFκB, iNOS, BMP-2 expression, glutathione (GSH), and thiobarbituric acid reactive substances (TBARS).</p><p><strong>Results: </strong>The Anti-inflammatory/Antioxidant mixture significantly reduced myeloperoxidase expression, osteoclast count, GSH, TBARS, and IL-1β levels on day 7. It also decreased NFκB, iNOS, and BMP-2 expression on days 3 and 7 compared to the Saline and Isolipidic groups.</p><p><strong>Conclusion: </strong>The Anti-inflammatory and Antioxidant mixture effectively reduced inflammation and oxidative stress during the inflammatory and proliferative phases of post-extraction healing, suggesting potential benefits in clinical applications for oral surgery recovery.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01892-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study evaluated the effects and mechanisms of antioxidant and anti-inflammatory oils with a high omega-9:omega-6 ratio and a low omega-6:omega-3 ratio on post-extraction healing in rats.
Materials and methods: A total of 128 Wistar rats were divided into four groups: Sham, Saline, Isolipidic, and Anti-inflammatory/Antioxidant. The animals received one of the following treatments: (1) 0.9% NaCl solution (Sham Group or Saline Group); (2) an isolipidic mixture containing alpha-linolenic acid (ALA) and a combination of ω-9, ω-6, and ω-3 fatty acids derived from corn oil and soybean oil-rich in omega-6:omega-3 and omega-9:omega-6 ratios (Isolipidic Group); or (3) an anti-inflammatory and antioxidant mixture containing ALA, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA), composed of olive oil (61%), canola oil (24%), and fish oil (15%) (Test Group). Treatments were administered by gavage for four days pre-extraction and three days post-surgery. Animals were euthanized at 3, 7, 14, and 21 days post-extraction. Blood and tissue samples were analyzed for myeloperoxidase, osteoclast count, IL-1β, NFκB, iNOS, BMP-2 expression, glutathione (GSH), and thiobarbituric acid reactive substances (TBARS).
Results: The Anti-inflammatory/Antioxidant mixture significantly reduced myeloperoxidase expression, osteoclast count, GSH, TBARS, and IL-1β levels on day 7. It also decreased NFκB, iNOS, and BMP-2 expression on days 3 and 7 compared to the Saline and Isolipidic groups.
Conclusion: The Anti-inflammatory and Antioxidant mixture effectively reduced inflammation and oxidative stress during the inflammatory and proliferative phases of post-extraction healing, suggesting potential benefits in clinical applications for oral surgery recovery.
期刊介绍:
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:
-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]